MYGN

#3012
Myriad Genetics Inc
4.8250 USD
+5.12%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
4.7850
4.8300
년간 변동
4.1050
8.5000
일일 변동
+5.12%
월간 변동
+3.54%
6달 변화
-41.66%
년간 변동율
-41.66%
이전 종가
4.5900
Open
4.8000
Bid
Ask
Low
4.7850
High
4.8300
양
160
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 451.1769 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.56
Price to sales ratio
0.69

Myriad Genetics Inc

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

뉴스